![Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals | Breast Cancer Research | Full Text Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals | Breast Cancer Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fbcr2832/MediaObjects/13058_2010_9463_Fig4_HTML.jpg)
Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals | Breast Cancer Research | Full Text
![Cisplatin with veliparib or placebo in metastatic triple-negative breast cancer and BRCA mutation-associated breast cancer (S1416): a randomised, double-blind, placebo-controlled, phase 2 trial - The Lancet Oncology Cisplatin with veliparib or placebo in metastatic triple-negative breast cancer and BRCA mutation-associated breast cancer (S1416): a randomised, double-blind, placebo-controlled, phase 2 trial - The Lancet Oncology](https://www.thelancet.com/cms/asset/708d05bb-a10a-4ae3-934f-7ea45a8e8bc2/gr1.jpg)
Cisplatin with veliparib or placebo in metastatic triple-negative breast cancer and BRCA mutation-associated breast cancer (S1416): a randomised, double-blind, placebo-controlled, phase 2 trial - The Lancet Oncology
![The Breast Information Core (BIC) Website Features. Overview and map of... | Download Scientific Diagram The Breast Information Core (BIC) Website Features. Overview and map of... | Download Scientific Diagram](https://www.researchgate.net/profile/Lawrence-Brody/publication/341397740/figure/fig3/AS:891331828260865@1589521476049/The-Breast-Information-Core-BIC-Website-Features-Overview-and-map-of-the-BIC-website_Q320.jpg)
The Breast Information Core (BIC) Website Features. Overview and map of... | Download Scientific Diagram
![Comparative oncogenomics identifies combinations of driver genes and drug targets in BRCA1-mutated breast cancer | Nature Communications Comparative oncogenomics identifies combinations of driver genes and drug targets in BRCA1-mutated breast cancer | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-019-08301-2/MediaObjects/41467_2019_8301_Fig1_HTML.png)
Comparative oncogenomics identifies combinations of driver genes and drug targets in BRCA1-mutated breast cancer | Nature Communications
![Identification of the most common BRCA alterations through analysis of germline mutation databases: Is droplet digital PCR an additional strategy for the assessment of such alterations in breast and ovarian cancer families? Identification of the most common BRCA alterations through analysis of germline mutation databases: Is droplet digital PCR an additional strategy for the assessment of such alterations in breast and ovarian cancer families?](https://www.spandidos-publications.com/article_images/ijo/60/5/IJO-60-05-05349-g02.jpg)
Identification of the most common BRCA alterations through analysis of germline mutation databases: Is droplet digital PCR an additional strategy for the assessment of such alterations in breast and ovarian cancer families?
![Genetics, tumor features and treatment response of breast cancer in Latinas | Breast Cancer Management Genetics, tumor features and treatment response of breast cancer in Latinas | Breast Cancer Management](https://www.futuremedicine.com/cms/10.2217/bmt-2017-0013/asset/images/medium/figure1.gif)
Genetics, tumor features and treatment response of breast cancer in Latinas | Breast Cancer Management
![Frontiers | Assessing the pathogenicity of BRCA1/2 variants of unknown significance: Relevance and challenges for breast cancer precision medicine Frontiers | Assessing the pathogenicity of BRCA1/2 variants of unknown significance: Relevance and challenges for breast cancer precision medicine](https://www.frontiersin.org/files/MyHome%20Article%20Library/1053035/1053035_Thumb_400.jpg)
Frontiers | Assessing the pathogenicity of BRCA1/2 variants of unknown significance: Relevance and challenges for breast cancer precision medicine
![Genes | Free Full-Text | Imprecise Medicine: BRCA2 Variants of Uncertain Significance (VUS), the Challenges and Benefits to Integrate a Functional Assay Workflow with Clinical Decision Rules Genes | Free Full-Text | Imprecise Medicine: BRCA2 Variants of Uncertain Significance (VUS), the Challenges and Benefits to Integrate a Functional Assay Workflow with Clinical Decision Rules](https://pub.mdpi-res.com/genes/genes-12-00780/article_deploy/html/images/genes-12-00780-g001.png?1621494142)
Genes | Free Full-Text | Imprecise Medicine: BRCA2 Variants of Uncertain Significance (VUS), the Challenges and Benefits to Integrate a Functional Assay Workflow with Clinical Decision Rules
![The Breast Cancer Information Core: Database design, structure, and scope - Szabo - 2000 - Human Mutation - Wiley Online Library The Breast Cancer Information Core: Database design, structure, and scope - Szabo - 2000 - Human Mutation - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/86452279-601c-4029-96e4-8be05a5b5cbe/humu.v43.12.cover.jpg?trick=1690526512678)
The Breast Cancer Information Core: Database design, structure, and scope - Szabo - 2000 - Human Mutation - Wiley Online Library
![BRCA1 and BRCA2 genes mutations among high risk breast cancer patients in Jordan | Scientific Reports BRCA1 and BRCA2 genes mutations among high risk breast cancer patients in Jordan | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-74250-2/MediaObjects/41598_2020_74250_Fig1_HTML.png)
BRCA1 and BRCA2 genes mutations among high risk breast cancer patients in Jordan | Scientific Reports
![PDF] Genotyping of BRCA 1 , BRCA 2 , p 53 , CDKN 2 A , MLH 1 and MSH 2 genes in a male patient with secondary breast cancer | Semantic Scholar PDF] Genotyping of BRCA 1 , BRCA 2 , p 53 , CDKN 2 A , MLH 1 and MSH 2 genes in a male patient with secondary breast cancer | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c9be17e10dba17347d1fb8b769919e19ce0b43e8/2-Table1-1.png)
PDF] Genotyping of BRCA 1 , BRCA 2 , p 53 , CDKN 2 A , MLH 1 and MSH 2 genes in a male patient with secondary breast cancer | Semantic Scholar
![Spectrum and prevalence of BRCA1/2 germline mutations in Pakistani breast cancer patients: results from a large comprehensive study | Hereditary Cancer in Clinical Practice | Full Text Spectrum and prevalence of BRCA1/2 germline mutations in Pakistani breast cancer patients: results from a large comprehensive study | Hereditary Cancer in Clinical Practice | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13053-019-0125-5/MediaObjects/13053_2019_125_Fig1_HTML.png)
Spectrum and prevalence of BRCA1/2 germline mutations in Pakistani breast cancer patients: results from a large comprehensive study | Hereditary Cancer in Clinical Practice | Full Text
![Addressing health disparities in Hispanic breast cancer: accurate and inexpensive sequencing of BRCA1 and BRCA2 – topic of research paper in Biological sciences. Download scholarly article PDF and read for free on Addressing health disparities in Hispanic breast cancer: accurate and inexpensive sequencing of BRCA1 and BRCA2 – topic of research paper in Biological sciences. Download scholarly article PDF and read for free on](https://cyberleninka.org/viewer_images/1379523/f/1.png)
Addressing health disparities in Hispanic breast cancer: accurate and inexpensive sequencing of BRCA1 and BRCA2 – topic of research paper in Biological sciences. Download scholarly article PDF and read for free on
![Diagnostics | Free Full-Text | Male Breast Cancer: Results of the Application of Multigene Panel Testing to an Italian Cohort of Patients Diagnostics | Free Full-Text | Male Breast Cancer: Results of the Application of Multigene Panel Testing to an Italian Cohort of Patients](https://www.mdpi.com/diagnostics/diagnostics-10-00269/article_deploy/html/images/diagnostics-10-00269-g001.png)
Diagnostics | Free Full-Text | Male Breast Cancer: Results of the Application of Multigene Panel Testing to an Italian Cohort of Patients
🌸 Join BIC Services in Honouring Breast Cancer Awareness Month! | BIC Services posted on the topic | LinkedIn
![High prevalence of BRCA1 and BRCA2 mutations in unselected Nigerian breast cancer patients - Fackenthal - 2012 - International Journal of Cancer - Wiley Online Library High prevalence of BRCA1 and BRCA2 mutations in unselected Nigerian breast cancer patients - Fackenthal - 2012 - International Journal of Cancer - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/bb05a6d2-a4df-4c73-92b5-2b611e81a7d8/ntbl001.jpg)
High prevalence of BRCA1 and BRCA2 mutations in unselected Nigerian breast cancer patients - Fackenthal - 2012 - International Journal of Cancer - Wiley Online Library
![The Breast Information Core (BIC) Website Features. Overview and map of... | Download Scientific Diagram The Breast Information Core (BIC) Website Features. Overview and map of... | Download Scientific Diagram](https://www.researchgate.net/publication/341397740/figure/fig3/AS:891331828260865@1589521476049/The-Breast-Information-Core-BIC-Website-Features-Overview-and-map-of-the-BIC-website.png)
The Breast Information Core (BIC) Website Features. Overview and map of... | Download Scientific Diagram
![Genes | Free Full-Text | Prevalence and Spectrum of BRCA Germline Variants in Central Italian High Risk or Familial Breast/Ovarian Cancer Patients: A Monocentric Study Genes | Free Full-Text | Prevalence and Spectrum of BRCA Germline Variants in Central Italian High Risk or Familial Breast/Ovarian Cancer Patients: A Monocentric Study](https://www.mdpi.com/genes/genes-11-00925/article_deploy/html/images/genes-11-00925-g001-550.jpg)
Genes | Free Full-Text | Prevalence and Spectrum of BRCA Germline Variants in Central Italian High Risk or Familial Breast/Ovarian Cancer Patients: A Monocentric Study
![Prevalence of Mutations in the BRCA 1 Gene Among Chinese Patients With Breast Cancer | Semantic Scholar Prevalence of Mutations in the BRCA 1 Gene Among Chinese Patients With Breast Cancer | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d8af561ead23934403a15d2dd408ed119333ec2c/2-Table1-1.png)
Prevalence of Mutations in the BRCA 1 Gene Among Chinese Patients With Breast Cancer | Semantic Scholar
![Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals | Breast Cancer Research | Full Text Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals | Breast Cancer Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fbcr2832/MediaObjects/13058_2010_9463_Fig8_HTML.jpg)